Search research articles
Contact Us
Filters
Showing results (241-250 of 286) with videos related to
Page
of 29
Sort By:
Blood
|
September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphoma
Csaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies
David W Scott, Pau Abrisqueta, George W Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
The Journal of Experimental Medicine
|
September 29, 2023
TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance
Elif Çakan, Marie Dominique Ah Kioon, Yolanda Garcia-Carmona, et al.
Blood Cancer Discovery
|
November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L Shaffer, James D Phelan, James Q Wang, et al.
Blood
|
September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry
Catalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Cancer Cell
|
January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
James D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Blood
|
August 13, 2017
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
Alyssa Bouska, Chengfeng Bi, Waseem Lone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.
Blood
|
December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
Javeed Iqbal, Yulei Shen, Xin Huang, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 286) with videos related to
Sort By:
Page
of 29
Blood
|
September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphoma
Csaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies
David W Scott, Pau Abrisqueta, George W Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells
Lesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
The Journal of Experimental Medicine
|
September 29, 2023
TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance
Elif Çakan, Marie Dominique Ah Kioon, Yolanda Garcia-Carmona, et al.
Blood Cancer Discovery
|
November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors
Arthur L Shaffer, James D Phelan, James Q Wang, et al.
Blood
|
September 29, 2019
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry
Catalina Amador, Timothy C Greiner, Tayla B Heavican, et al.
Cancer Cell
|
January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
James D Phelan, Sebastian Scheich, Jaewoo Choi, et al.
Blood
|
August 13, 2017
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
Alyssa Bouska, Chengfeng Bi, Waseem Lone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2019
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303
Nancy L Bartlett, Wyndham H Wilson, Sin-Ho Jung, et al.
Blood
|
December 16, 2014
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma
Javeed Iqbal, Yulei Shen, Xin Huang, et al.
Page
of 29